148 related articles for article (PubMed ID: 11025865)
21. Estradiol and Follicle-Stimulating Hormone as Predictors of Onset of Menopause Transition-Related Bone Loss in Pre- and Perimenopausal Women.
Shieh A; Greendale GA; Cauley JA; Karvonen-Gutierrez C; Crandall CJ; Karlamangla AS
J Bone Miner Res; 2019 Dec; 34(12):2246-2253. PubMed ID: 31442329
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women.
Atalay S; Elci A; Kayadibi H; Onder CB; Aka N
Ann Lab Med; 2012 Jan; 32(1):23-30. PubMed ID: 22259775
[TBL] [Abstract][Full Text] [Related]
23. Serum follicle stimulating hormone and estradiol in peri/postmenopausal women attending Siriraj Menopause Clinic: a retrospective study.
Angsuwathana S; Tanmahasamut P; Rattanachaiyanont M; Dangrat C; Techatrisak K; Indhavivadhana S; Leerasiri P
J Med Assoc Thai; 2006 Aug; 89(8):1101-8. PubMed ID: 17048416
[TBL] [Abstract][Full Text] [Related]
24. Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition.
Crandall CJ; Tseng CH; Crawford SL; Thurston RC; Gold EB; Johnston JM; Greendale GA
J Bone Miner Res; 2011 Apr; 26(4):840-9. PubMed ID: 20878774
[TBL] [Abstract][Full Text] [Related]
25. Urinary beta-FSH subunit concentrations in perimenopausal and postmenopausal women: a biomarker for ovarian reserve.
Liu JH; Kao L; Rebar RW; Muse K
Menopause; 2003; 10(6):526-33. PubMed ID: 14627861
[TBL] [Abstract][Full Text] [Related]
26. Bone metabolism during the perimenopausal transition: a prospective study.
Seifert-Klauss V; Mueller JE; Luppa P; Probst R; Wilker J; Höss C; Treumann T; Kastner C; Ulm K
Maturitas; 2002 Jan; 41(1):23-33. PubMed ID: 11809340
[TBL] [Abstract][Full Text] [Related]
27. Incidence of ovulation in perimenopausal women before and during hormone replacement therapy.
Gebbie AE; Glasier A; Sweeting V
Contraception; 1995 Oct; 52(4):221-2. PubMed ID: 8605779
[TBL] [Abstract][Full Text] [Related]
28. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
Schipper I; Hop WC; Fauser BC
J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
[TBL] [Abstract][Full Text] [Related]
29. Vitamin K nutritional status and undercarboxylated osteocalcin in postmenopausal osteoporotic women treated with bisphosphonates.
Iwamoto J; Takada T; Sato Y
Asia Pac J Clin Nutr; 2014; 23(2):256-62. PubMed ID: 24901095
[TBL] [Abstract][Full Text] [Related]
30. Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III.
Gallagher CM; Moonga BS; Kovach JS
Environ Res; 2010 Jan; 110(1):105-11. PubMed ID: 19875111
[TBL] [Abstract][Full Text] [Related]
31. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
32. One-year spinal bone change in pre- and perimenopausal Japanese women. A prospective observational study.
Komukai S; Ohta H; Makita K; Yanamoto S; Takamatsu K; Okano H; Yajima M; Nozawa S
Horm Res; 2003; 59(2):79-84. PubMed ID: 12589111
[TBL] [Abstract][Full Text] [Related]
33. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.
Sherman BM; West JH; Korenman SG
J Clin Endocrinol Metab; 1976 Apr; 42(4):629-36. PubMed ID: 1262439
[TBL] [Abstract][Full Text] [Related]
34. Antioxidant status and reproductive hormones in women during reproductive, perimenopausal and postmenopausal phase of life.
Ogunro PS; Bolarinde AA; Owa OO; Salawu AA; Oshodi AA
Afr J Med Med Sci; 2014 Mar; 43(1):49-57. PubMed ID: 25335378
[TBL] [Abstract][Full Text] [Related]
35. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
[TBL] [Abstract][Full Text] [Related]
36. Impaired folliculogenesis and ovulation in older reproductive aged women.
Santoro N; Isaac B; Neal-Perry G; Adel T; Weingart L; Nussbaum A; Thakur S; Jinnai H; Khosla N; Barad D
J Clin Endocrinol Metab; 2003 Nov; 88(11):5502-9. PubMed ID: 14602797
[TBL] [Abstract][Full Text] [Related]
37. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles.
Klein NA; Illingworth PJ; Groome NP; McNeilly AS; Battaglia DE; Soules MR
J Clin Endocrinol Metab; 1996 Jul; 81(7):2742-5. PubMed ID: 8675606
[TBL] [Abstract][Full Text] [Related]
38. Changes in biochemical markers of osteoblastic activity during the menstrual cycle.
Nielsen HK; Brixen K; Bouillon R; Mosekilde L
J Clin Endocrinol Metab; 1990 May; 70(5):1431-7. PubMed ID: 2110577
[TBL] [Abstract][Full Text] [Related]
39. Undercarboxylated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days.
Yasui T; Uemura H; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Menopause; 2006; 13(2):314-22. PubMed ID: 16645545
[TBL] [Abstract][Full Text] [Related]
40. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
